The risk of invasive pneumococcal disease differs between risk groups in Norway following widespread use of the 13-valent pneumococcal vaccine in children

dc.contributor.author	Winje, Brita Askeland
dc.contributor.author	Vestrheim, Didrik Frimann
dc.contributor.author	White, Richard Aubrey
dc.contributor.author	Steens, Anneke
dc.date.accessioned	2021-12-03T07:21:09Z
dc.date.available	2021-12-03T07:21:09Z
dc.date.created	2021-09-28T16:21:44Z
dc.date.issued	2021
dc.identifier.citation	Microorganisms. 2021, 9 (8), 1-14.
dc.identifier.issn	2076-2607
dc.identifier.uri	https://hdl.handle.net/11250/2832662
dc.language.iso	eng
dc.title	The risk of invasive pneumococcal disease differs between risk groups in Norway following widespread use of the 13-valent pneumococcal vaccine in children
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.source.pagenumber	1-14
dc.source.volume	9
dc.source.journal	Microorganisms
dc.source.issue	8
dc.identifier.doi	10.3390/microorganisms9081774
dc.identifier.cristin	1940021
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1